| Net loss | -5.67M |
| ESOP expense | 10K |
| Stock-based incentive plan expense | 143K |
| Depreciation and amortization | 386K |
| Provision for loan losses | 3.15M |
| Income from bank-owned life insurance | -221K |
| Gross loss on OTTI recognized in earnings | 8K |
| Amortization of servicing rights | 43K |
| Accretion of deferred loan fees, net | -787K |
| Amortization of premiums, net of discounts | -14K |
| Originations of loans held-for-sale | -4.37M |
| Proceeds from sales of loans held-for-sale | 4.48M |
| Principal repayments on loans held-for-sale | 0 |
| Net gain on sales of loans held-for-sale | -104K |
| Decrease in accrued interest receivable | 909K |
| Deferred income tax expense (benefit) | 949K |
| Net loss on sales of securities available-for-sale | 1.39M |
| Decrease (increase) in prepaid expenses and other assets | 2.5M |
| Increase (decrease) in accrued expenses and other liabilities | 2.46M |
| Net cash provided by operating activities | 5.25M |
| Repayments in excess of loan originations | 35.36M |
| Proceeds from the sale of loan notes | 55.64M |
| Principal repayments on mortgage-backed securities held-to-maturity | 0 |
| Principal repayments on mortgage-backed securities available-for-sale | 27.04M |
| Purchases of mortgage-backed securities held-to-maturity | 0 |
| Purchases of securities available-for-sale | -103.8M |
| Proceeds from the sale of securities available-for-sale | 13.04M |
| Net redemptions of FHLB stock | 160K |
| Purchases of bank-owned life insurance | -15K |
| Proceeds from surrender of bank-owned life insurance | 3.21M |
| Purchases of premises and equipment | -158K |
| Net cash provided by (used in) investing activities | 30.48M |
| (Decrease) increase in deposits | -12.64M |
| Net decrease in short term borrowings | -1.5M |
| Proceeds from long term borrowings | 0 |
| Decrease in advance payments by borrowers for taxes and insurance | -1.15M |
| Purchase of treasury shares | -8K |
| Payment of cash dividend | 0 |
| Net cash (used in) provided by financing activities | -15.29M |
| Net increase in cash and cash equivalents | 20.44M |
| Cash and cash equivalents at beginning of year | 14.2M |
| Cash and cash equivalents at end of period | 34.64M |
| Interest | 4.53M |
| Taxes | 175K |
| Securities held-for-sale transferred to available-for-sale | 0 |